← All companies

KYNB

Kyntra Bio, Inc.

KYNB Nasdaq Pharmaceutical Preparations EDGAR ↗

$6.76

+0.03 +0.45%

Key statistics

from XBRL data in SEC filings

Market cap

$27.4M

Revenue (TTM)

$7.44M

Net income (TTM)

$164M

EPS (TTM)

$40.46

P/E ratio

0.2

Dividend yield

—

Free cash flow

-$4.81M

Cash

$37.0M

Total assets

$110M

Gross margin

—

52-week range

$6.32 – $12.60

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 16, 2026 8-K Other events Jun 9, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 11, 2026 8-K Delisting notice or listing-rule failure Apr 9, 2026 10-K Fiscal year ended 2025-12-31 Mar 16, 2026 8-K Results of operations (earnings release) Mar 16, 2026 8-K Amended charter or bylaws; Other events Jan 7, 2026 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 8-K Other events Nov 6, 2025 8-K Completed an acquisition or disposition Sep 5, 2025 8-K Other events Sep 2, 2025 8-K Other events Aug 18, 2025 8-K Entered a material agreement Aug 14, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release) Aug 11, 2025 8-K Entered a material agreement Jul 14, 2025 8-K Terminated a material agreement Jun 13, 2025 8-K Modified rights of security holders; Amended charter or bylaws Jun 12, 2025 8-K Entered a material agreement; Director or officer change; Shareholder vote results Jun 9, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 8-K Amended charter or bylaws Apr 4, 2025 8-K Regulation FD disclosure Mar 31, 2025 8-K Entered a material agreement Mar 28, 2025 10-K Fiscal year ended 2024-12-31 Mar 17, 2025 8-K Results of operations (earnings release); Delisting notice or listing-rule failure Mar 17, 2025 8-K Entered a material agreement Feb 24, 2025 8-K Entered a material agreement; Results of operations (earnings release); Director or officer change; Regulation FD disclosure Feb 20, 2025 8-K Director or officer change Dec 16, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Terminated a material agreement Oct 3, 2024 8-K Delisting notice or listing-rule failure Sep 16, 2024 8-K Director or officer change Sep 13, 2024 8-K Director or officer change Sep 6, 2024 8-K Exit or disposal costs Aug 7, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024